Weill Cornell Medicine Multiple Sclerosis Imaging Research
As novel therapeutics focused on repair and neuroprotection are developed for multiple sclerosis, the need for accurate markers to measure the disease is essential in order to translate these agents from the lab to clinical trials in patients with MS. Our imaging program is a novel multi-modality program for MS, which includes both MRI and Positron Emission Tomography (PET). We focus our efforts on developing new methods to measure ongoing myelin and nerve damage in patients with MS.
Our imaging research program, led by Dr. Susan Gauthier, is a collaborative effort between the Weill Cornell Medical College Departments of Neurology, Radiology and Nuclear Medicine. Dr. Ashish Raj leads a team of doctorate-level computer scientists at the Imaging Data Evaluation and Analytics Lab (IDEAL); members of his team work closely with physicist Thanh Nguyen and Dr. Gauthier to create new approaches for the use of MRI to monitor disease progression in MS. The PET aspect of our program is a collaborative effort with Dr. Shankar Vallabhajosula, Department of Radiology professor of radiochemistry and radiopharmacy. Dr. Vallabhajosula is a senior molecular imaging investigator at Weill Cornell Medical College, and the director of nuclear medicine and PET research at the Citigroup Biomedical Imaging Center (CBIC). Members of our MRI and PET teams work together to understand how both methods can be used together to improve our ability to measure myelin and nerve damage in MS. Translation of laboratory discoveries is facilitated through our animal imaging program.